2 active not recruiting, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Recruiting 1 |
Follow Penile Carcinoma: new trials by email Literature Review of Penile Carcinoma trials Research Report on Penile Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer Administration of CC-3 - Colorectal Cancer, Breast Carcinoma | Phase 1 | Recruiting | German Cancer Research Center | 89 | 2024-01-12 | 2025-05-21 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 152 | 2015-07-22 | 2026-10-15 |
Penile Neoplasms (3) · Breast Neoplasms (2) · Colorectal Neoplasms (2) · Sarcoma (2) · Urinary Bladder Neoplasms (2) · Adrenal Gland Neoplasms (1) · Anus Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Cholangiocarcinoma (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1)
Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Penile Diseases (3) · Urogenital Diseases (3) · Adenocarcinoma (2) · Breast Diseases (2) · Carcinoma (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2)
Magnetic Resonance Spectroscopy (2) · Biopsy (1) · CTLA-4 Antigen (1) · FAPI-46 (1) · Fluorodeoxyglucose F18 (1) · Ipilimumab (1) · Nivolumab (1) · Specimen Handling (1) · cabozantinib (1)
German Cancer Research Center (1) · Jonsson Comprehensive Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2) · Germany (1)
Andrea B Apolo (1) · Jeremie Calais (1)
PMID 32915679, PMID 35031545, PMID 38954785, PMID 40881578, PMID 42094867
UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1), ZIABC011078 (1)